Heart Disease - Articles, News and Resources on Prevention Coronary Heart Disease Type 2 Diabetes Mellitus
Main Prevention Coronary Heart Disease Type 2 Diabetes Mellitus resources
Prevention Coronary Heart Disease Type 2 Diabetes Mellitus Navigation
Heart Disease Research
Heart Disease Dental Health
Heart Disease Risk Factors
How Does Cortisol Cause Coronary Heart Disease
Prevent Heart Disease
Health Heart Disease
How Is Obesity Influence By Heart Disease
Is There A Link Between Heart Disease And Oral Health
Cure For Coronary Heart Disease Alternative
Heart Disease Red Dress Pin
Community Health Fairs For Heart Disease In Women
Medications For Heart Disease In Dogs
Life Expectancy Of Coronary Heart Disease
Heart Disease And Men
Heart Disease Diabetes Link
Nutrition Health Amp Heart Disease Cause
Physical Inactivity And Coronary Heart Disease
Bextra And Heart Disease
Hot Tubs And Heart Disease
Heart Disease Dental Health
Hypertensive Heart Disease
How Coronary Heart Disease Can Be Prevented
Congenital Heart Disease In Child
Statistics About Heart Disease
Red Dress Heart Disease Awarenessprevention
Latest Prevention Coronary Heart Disease Type 2 Diabetes Mellitus link added
INSERT YOUR OWN BANNER HERE
Welcome to Heart Disease
Prevention Coronary Heart Disease Type 2 Diabetes Mellitus News
ACC: Devices May Trump Drugs in Atlanta - MedPage Today
ACC: Devices May Trump Drugs in Atlanta MedPage Today Another long-anticipated presentation will bring results from the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial, which is slated for ... |
Glycemic Control in Diabetic ESRD Patients - Renal and Urology News
 The Hindu | Glycemic Control in Diabetic ESRD Patients Renal and Urology News Whether reaching glycemic goals in type 2 diabetes could prevent cardiovascular events has been addressed in two large randomized double-blind trials in ... Incidence of CKD increasing in India alonwith Diabetes:Experts |
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the ... - MarketWatch (press release)
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the ... MarketWatch (press release) The five-year study will follow approximately 12000 patients with type 2 diabetes, who have either a history of previous cardiovascular events or multiple ... Bristol-Myers, AstraZeneca Commence Saxagliptin Assessment Of Vascular ... Bristol-Myers Squibb, AstraZeneca announce postmarketing study for Onglyza |
Docs Often Miss Lipid Targets, More So with Women - MedPage Today
Docs Often Miss Lipid Targets, More So with Women MedPage Today ... of a correct estimate, including a previous myocardial infarction, history of coronary artery disease, and confirmed diagnosis of diabetes mellitus. ... |
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial ... - MarketWatch (press release)
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial ... MarketWatch (press release) In the GSK clinical pipeline, darapladib for cardiovascular disease and Syncria(R) for type 2 diabetes are both moving through Phase 3 trials. ... |
BMS & AstraZeneca begin phase-4 trial of Saxgliptin in type-2 diabetes with ... - pharmabiz.com
BMS & AstraZeneca begin phase-4 trial of Saxgliptin in type-2 diabetes with ... pharmabiz.com The five-year study will follow approximately 12000 patients with type-2 diabetes, who have either a history of previous cardiovascular events or multiple ... |